Navigation Links
Surgical technique halts cell loss, Parkinson's researchers find
Date:9/2/2008

CINCINNATIDeep brain stimulation, a surgical technique often viewed as a last resort for people with Parkinson's disease, halts the progression of dopamine-cell loss in animal models, according to preliminary research by scientists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.

The scientists also discovered clues to why the technique works. The act of stimulating neurons with electrodes boosted the amount of an important protein in animals' brains. The protein, a trophic factor known as BDNF (brain-derived neurotrophic factor), is a nurturing, growth-promoting chemical.

Parkinson's disease is a degenerative neurological disorder involving the death of dopamine-producing brain cells, or neurons.

"Demonstrating that deep brain stimulation halts the progression of dopamine-cell loss was basically a confirmation and extension of previous findings," says Caryl Sortwell, PhD, associate professor of neurology at UC and the study's lead investigator. "But finding the mechanism is a novel discovery that is even more critical. We now know not only that it works, we also are beginning to understand how it is working."

Sortwell recently announced her team's results at a professional conference held by the Cleveland Clinic and the National Institute of Neurological Disorders and Stroke.

The research holds important implications for patients with Parkinson's disease and could alter the current recommended timetable for surgical intervention.

In a typical treatment scenario, a patient has lost about 50 percent of his or her dopamine-producing neurons when symptoms first appear and a diagnosis is made. The typical patient then waits an average of 14 additional years before undergoing deep brain stimulation surgery. During that 14-year span, medications can offer symptomatic relief, but cell loss continues unabated. There is at present no cure for the disease.

Sortwel
'/>"/>

Contact: Cindy Starr
cstarr@mayfieldclinic.com
513-569-5321
University of Cincinnati
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
2. Older Adults Reluctant to Question Surgical Treatment
3. Study shows that surgical weight loss does not eliminate obstructive sleep apnea
4. Specialty Surgery Center to Partner With Surgical Care Affiliates
5. STAAR Surgical to Present at the Noble Financial Equity Conference
6. Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
7. New Steril-Eze Surgical Case Carts from Eagle MHC Feature Rugged, Easy-Clean Design
8. Surgical Errors Cost Almost $1.5B a Year
9. New AHRQ Study Finds Surgical Errors Cost Nearly $1.5 Billion Annually
10. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
11. ORSupply.com Remodels, Improves Online Surgical Supply Store

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., NEW YORK, Nov. 9 Th...l make its world television debut on the Sundance ...8 p.m. EST/PST. ,, Directed by Academy Award&#...journeys of children with type 1 diabetes amid the...one the world,s poorest countries. The children ar...
(Date:11/9/2009)...tudy didn,t answer question of why this is so, how...s) -- After a lumpectomy, women with very dense br...he affected breast, a new study shows. , Breast... risk of developing breast cancer, and experts hav...sociated with an increased risk of cancer recurren...
(Date:11/9/2009)..., WASHINGTON, Nov. 9 ...ement praising provisions in the Affordable Health...prove access to Medicaid and reduce Medicare Part ... passed the House on Saturday by a vote of 220 to ...ed both health and quality of life for thousands o...
(Date:11/9/2009)..., CAMBRIDGE, Mass., Nov. 9 Ab...d capabilities in delivering emergency management ...y awarded contracts to support the work of the Fed...f Regional Operations, the National Commission on ...itan Area Transit Authority (WMATA). The value of...
(Date:11/9/2009)..., - Parents Support Experimental Procedure fo...wswire-USNewswire/ -- For parents of children with...al rates have steadily improved for decades. Among...ften cause infertility. ,, Boys diagnosed wit...n opportunity to preserve their fertility: before ...
Breaking Medicine News(10 mins):Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4
...N.J., Oct. 2 Abbott (NYSE: ABT ),announced today...has,granted waived status under the Clinical Labor...ts handheld i-STAT CHEM8+ test cartridge, making i... broadly available to healthcare providers where f...
...fornia, October 2 joimax GmbH, Campbell,CA, is pl...irements by,joimax, Inc. the company is moving to ...S operations are based. As of October 1st, 2007,jo...US market,",comments Michael Stek, CEO of the joim...
...N.Y., Oct. 2 Genetic Engineering and,Biotechnolog...viewed by,over 850 visitors and picked up by more ...his month. The video, which is the first to run on...ww.prnewswire.com/mnr/gen/29564/ "We are absolut...
...2 Nutrition Systems, LLC has added over,6,000 men...nd family dining,restaurant chains to http://www....rch engine. NutritionPedia users can now quickly f...s,Applebee,s Neighborhood Bar and Grill, Golden Co...
...ctober 2nd, 2007 - From Microscope to Stethoscope,... by the Research Institute of the McGill Universit... season tomorrow. , For this opening conference, ...uffering from Alzheimers disease. Alzheimers disea...
...nts Position as Leading ,Single Source, Provider f...y Solutions, HATBORO, Pa., Oct. 2 InfoLogix, Inc... mobile enterprise solutions for the,healthcare an...al systems consulting company dedicated to the hea...
Other Medicine News:Health News:Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge 2Health News:Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge 3Health News:Video: GEN Video Hits Home with Web Audience 2Health News:NutritionPedia Adds Nutrition Facts for Over 6,000 Menu Items From 70 Leading Fast-Casual and Family Dining Restaurant Chains 2Health News:InfoLogix Acquires Healthcare Informatics Associates Inc. (HIA); Adds Premier Healthcare Consulting Firm and Systems Integrator 2Health News:InfoLogix Acquires Healthcare Informatics Associates Inc. (HIA); Adds Premier Healthcare Consulting Firm and Systems Integrator 3Health News:InfoLogix Acquires Healthcare Informatics Associates Inc. (HIA); Adds Premier Healthcare Consulting Firm and Systems Integrator 4
(Date:11/9/2009)... Women,s sexual health company, Ti...Viveve as it prepares for a 2010 launch of its Viv..., "Viveve is a name that we believe captures the e...th," said Kerry Pope, Viveve,s president and chief... helping women restore their sense of fulfillment ...
(Date:11/9/2009)... 9 LifeNet Health, a leading allog...Vertigraft Cervical Bio-Implant (VG2C) with Preser...w, proprietary glycerol-based preservation solutio...in a fully hydrated state at ambient temperature. ...io-implants, doing away with lengthy thawing and r...
(Date:11/9/2009)...Newswire-FirstCall/ -- RBC Life Sciences, Inc. ...tary nutritional supplements and wound care/pain m...100 workplaces in the Dallas-Fort Worth area. ,...100 Places to Work 2009 competition surveyed more ... and large firms throughout the DFW metropolitan a...
Breaking Medicine Technology:Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area 2Edmond Scientific Company Rallies as Certifications 26 Assessments 28C 26A 29 Provider for HIEs Pursuing ARRA ONC Grants 55743 1Edmond Scientific Company Rallies as Certifications 26 Assessments 28C 26A 29 Provider for HIEs Pursuing ARRA ONC Grants 55743 2SCOLR Pharma Inc Appoints Stephen J Turner as CEO 55740 1SCOLR Pharma Inc Appoints Stephen J Turner as CEO 55740 2SCOLR Pharma Inc Appoints Stephen J Turner as CEO 55740 3New Study of House Health Reform Bill 3A New Mexico Faces Over 24130 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55737 1New Study of House Health Reform Bill 3A New Mexico Faces Over 24130 Million in Medicare Funded Nursing Home Cuts Over Ten Years 55737 2
... Orexigen(R) Therapeutics, Inc.,(Nasdaq: OREX )... resources,focus its efforts on its late-stage obe... The key aspects of these changes are as follo...hase 2 trials for OREX-003,(zonisamide and olanzap...in),and OREX-004 (fluoxetine and naltrexone to red...
...LR8 Agonist to Advance to Clinical Trials , , ... a biopharmaceutical company focused on the develo...s for the treatment of cancer, respiratory and aut...iated a Phase I clinical trial of VTX-2337, a sele...he multi-center clinical trial is being conducted ...
Other Medicine Technology:Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 2Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team 3VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2
...500, water-cooled secondary condenser to trap resi...00 is a powerful PTFE membrane vacuum pump designe...s Ideally suited for use with up to two rotary e...nts including vacuum ovens, concentrators, gel dry...
...500 and water-cooled secondary condenser to trap r...TFE membrane vacuum pump designed to handle most v... for use with up to two rotary evaporators Labor...um ovens, concentrators, gel dryers, and filtratio...
Vacuum Pump (230 V, 50 Hz)
...V-500 with Vacuum Controller V-800 Efficiently c...mechanism turns V-500 on and off as needed to main... V-500 is a powerful PTFE membrane vacuum pump des...tions Ideally suited for use with up to two rota...
Medicine Products: